Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SpectraScience, Inc.

This article was originally published in The Gray Sheet

Executive Summary

Firm nets approximately $4.2 mil. through a series of transactions, including a $3.5 mil. private placement, $396,804 in stock option exercises and $600,000 from an equity securities transaction. The funds improve the firm's financial position following a recent move to an expanded manufacturing facility and positive FDA panel review of its Virtual Biopsy system. The agency's Gastroenterology and Urology Devices Panel voted 4-3 to recommend approval of the laser-induced fluorescence technology on Nov. 19 (1"The Gray Sheet" Nov. 29, p. 3)
Advertisement

Related Content

SpectraScience Virtual Biopsy Can Reduce Unnecssary Colonoscopies
SpectraScience Virtual Biopsy Can Reduce Unnecssary Colonoscopies
Advertisement
UsernamePublicRestriction

Register

MT012899

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel